Virology Specimen Collection Market: Trends & Forecasts
- The virology specimen collection market is seeing substantial growth,fueled primarily by the increasing prevalence of viral diseases,including human papillomavirus (HPV) and cervical cancer.
- The emergence of new pathogens, such as the Zika virus and Babesia, has underscored the need for advancements in virology specimen collection technologies.Countries are implementing initiatives to monitor...
- In 2020, viral transport media accounted for the largest share of the virology specimen collection market, segmented by product.
The virology specimen collection market is experiencing robust growth, primarily due to the escalating prevalence of viral diseases like HPV, and the rise in blood donations. Viral transport media currently dominates the market by product type,reflecting the urgent need for advanced specimen collection methods. the blood segment projects the highest growth rate, propelled by increased donations and disease prevalence. north America leads the global market share. News Directory 3 has the latest on market dynamics. Discover what’s next as innovation and enhanced screening efforts further propel this dynamic market.
virology specimen Collection Market Shows Strong Growth
The virology specimen collection market is seeing substantial growth,fueled primarily by the increasing prevalence of viral diseases,including human papillomavirus (HPV) and cervical cancer. A rise in blood donations is also contributing to the market’s expansion.
The emergence of new pathogens, such as the Zika virus and Babesia, has underscored the need for advancements in virology specimen collection technologies.Countries are implementing initiatives to monitor and control both new and existing diseases. As an example, the prevalence of malaria in Africa, coupled with the risk of mosquito-borne Zika transmission, has led to mandates for Zika virus screening in the region.
In 2020, viral transport media accounted for the largest share of the virology specimen collection market, segmented by product. This is attributed to the rising prevalence of viral diseases and the emergence of newer pathogens.
The blood segment is expected to register the highest growth rate. This growth is driven by the increasing number of blood donations and the rising prevalence of viral diseases.
North America held the largest share of the global virology specimen collection market in 2020, due in part to the increasing number of blood donations in the region.
Key players in the virology specimen collection market include Becton, Dickinson and Company (US), Quidel Corporation (US), and Thermo Fisher Scientific, Inc. (US), among others.
What’s next
Continued innovation in specimen collection technologies and increased screening efforts are expected to further propel the growth of the virology specimen collection market.